Haemtech Biopharma Services

PPTA Meeting – Washington D.C. – June 2017

Please visit us in booth “C” at the Plasma Protein Therapeutics Association meeting in Washington, D.C. June 2017. Learn more here: http://www.pptaglobal.org/meetings-events/plasma-protein-forum

Visit us at the Preclinical Development Operations Summit 2016 in Boston November 15-16!

The Preclinical Development Operations Summit aims to provide an interactive platform for the industry to debate, discuss and share best practices on topics such as vendor management and selection, preclinical data requirements, attaining funding and IND drafting and submission. To

Read more ›

Characterization of IXINITY®, recombinant factor IX from Emergent BioSolutions, Inc.

Here is an article in Advanced Hematology (February 2016) illustrating some of our work characterizing recombinant FIX from Emergent BioSolutions, Inc. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779506/

Visit us at the Plasma Protein Therapeutics Assn. (PPTA) Meeting in D.C.!

The Plasma Protein Forum is the premier conference for the plasma protein therapeutics industry in North America. Held annually each June, the Forum brings industry, policymakers, physicians, scientists and patients together to learn about key developments and issues. Haemtech will

Read more ›

Haemtech Biopharma Services Validates First Thrombin Generation Assay for Commercial IVIG Product Release


Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals

Read more ›